Re:A shot to prevent Lyme disease could be on its way
by acdha on Tuesday August 17, 2021 @03:32PM
(#28213876)
I'm not saying it's perfect but rather that the skepticism you're looking for is found within the process where many scientists who are not employed by the vendor review the test results, methodology, and side effects. By the time something gets through approval, it's been tested in thousands of people with monitoring over a substantial time period (even the EUA COVID vaccines were monitored for a period of time longer than vaccine side effects have historically been observed) and reviewed by hundreds of people.
We actually have an interesting example which I think validates that process even though it comes in the unlikely form of the FDA's recent mistake approving Aducanumab. There is a lot of criticism, including IG investigations, over the approval because it was approved despite having failed to go through the process successfully. The Phase III trials were cancelled after they concluded that the drug was not successful, the FDA's internal scientific review found it did not meet the mark, and the outside scientific advisory panel rejected it so strongly that multiple panel members resigned after it was approved anyway. That to me seems like a pretty good argument that the process was doing what we expect and the way to avoid expensive mistakes is to follow it.
We actually have an interesting example which I think validates that process even though it comes in the unlikely form of the FDA's recent mistake approving Aducanumab. There is a lot of criticism, including IG investigations, over the approval because it was approved despite having failed to go through the process successfully. The Phase III trials were cancelled after they concluded that the drug was not successful, the FDA's internal scientific review found it did not meet the mark, and the outside scientific advisory panel rejected it so strongly that multiple panel members resigned after it was approved anyway. That to me seems like a pretty good argument that the process was doing what we expect and the way to avoid expensive mistakes is to follow it.